UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Kinase Inhibitors: The Reality Behind the Success

Clinical pharmacology and therapeutics, 2017-11, Vol.102 (5), p.726-730

2017

Volltextzugriff (PDF)

E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia

Leukemia, 2017-02, Vol.31 (2), p.502-505

2017

Volltextzugriff (PDF)

The effects of pazopanib on doxorubicin pharmacokinetics in children and adults with non-rhabdomyosarcoma soft tissue sarcoma: a report from Children’s Oncology Group and NRG Oncology study ARST1321

Cancer chemotherapy and pharmacology, 2022-04, Vol.89 (4), p.551-557

2022

Volltextzugriff (PDF)

Inherited variation in OATP1B1 is associated with treatment outcome in acute myeloid leukemia

Clinical pharmacology and therapeutics, 2016-06, Vol.99 (6), p.651-660

2016

Volltextzugriff (PDF)

Irinotecan Pathway Genotype Analysis to Predict Pharmacokinetics

Clinical cancer research, 2003-08, Vol.9 (9), p.3246-3253

2003

Volltextzugriff (PDF)

Pharmacokinetic Considerations for New Targeted Therapies

Clinical pharmacology and therapeutics, 2009-02, Vol.85 (2), p.208-211

2009

Volltextzugriff (PDF)

Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity

Clinical and translational science, 2017-09, Vol.10 (5), p.412-420

2017

Volltextzugriff (PDF)

Pharmacokinetics of 5-Azacitidine Administered With Phenylbutyrate in Patients With Refractory Solid Tumors or Hematologic Malignancies

Journal of clinical oncology, 2005-06, Vol.23 (17), p.3906-3911

2005

Volltextzugriff (PDF)

Influence of OATP1B1 Function on the Disposition of Sorafenib‐β‐D‐Glucuronide

Clinical and translational science, 2017-07, Vol.10 (4), p.271-279

2017

Volltextzugriff (PDF)

Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy

Molecular cancer therapeutics, 2002-05, Vol.1 (7), p.545

2002

Volltextzugriff (PDF)

OATP1B1 Polymorphism as a Determinant of Erythromycin Disposition

Clinical pharmacology and therapeutics, 2012-11, Vol.92 (5), p.642-650

2012

Volltextzugriff (PDF)

A Phase I Dose Escalation and Bioavailability Study of Oral Sodium Phenylbutyrate in Patients with Refractory Solid Tumor Malignancies

Clinical cancer research, 2001-08, Vol.7 (8), p.2292-2300

2001

Volltextzugriff (PDF)

ABCC4 Is a Determinant of Cytarabine‐Induced Cytotoxicity and Myelosuppression

Clinical and translational science, 2016-02, Vol.9 (1), p.51-59

2016

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function

Journal of clinical oncology, 2006-02, Vol.24 (4), p.552-562

2006

Volltextzugriff (PDF)

Tumor Targeting by Covalent Conjugation of a Natural Fatty Acid to Paclitaxel

Clinical cancer research, 2001-10, Vol.7 (10), p.3229-3238

2001

Volltextzugriff (PDF)

Ductal access for prevention and therapy of mammary tumors

Cancer research (Chicago, Ill.), 2006-01, Vol.66 (2), p.638-645

2006

Volltextzugriff (PDF)

Germline Polymorphisms in EGFR and Survival in Patients With Lung Cancer Receiving Gefitinib

Clinical pharmacology and therapeutics, 2008-03, Vol.83 (3), p.477-484

2008

Volltextzugriff (PDF)

Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometry

Analytical biochemistry, 2004-01, Vol.324 (2), p.276-284

2004

Volltextzugriff (PDF)

Population Pharmacokinetic Model for Docetaxel in Patients with Varying Degrees of Liver Function: Incorporating Cytochrome P450 3A Activity Measurements

Clinical pharmacology and therapeutics, 2008-07, Vol.84 (1), p.111-118

2008

Volltextzugriff (PDF)

Residual feed intake of purebred Angus steers: effects on meat quality and palatability

Journal of animal science, 2006-04, Vol.84 (4), p.938-945

2006

Volltextzugriff (PDF)

Effect of Common CYP3A4 and CYP3A5 Variants on the Pharmacokinetics of the Cytochrome P450 3A Phenotyping Probe Midazolam in Cancer Patients

Clinical cancer research, 2005-10, Vol.11 (20), p.7398-7404

2005

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Short Infusions of UCN-01 in Patients with Refractory Solid Tumors

Clinical cancer research, 2005-01, Vol.11 (2), p.664-671

2005

Volltextzugriff (PDF)

Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: a dose escalation and pharmacologic study

Neuro-oncology (Charlottesville, Va.), 2005-04, Vol.7 (2), p.177-182

2005

Volltextzugriff (PDF)

College Students' Perceptions of MyPlate and ChooseMyPlate.gov

Journal of the American Dietetic Association, 2013-09, Vol.113 (9), p.A_82

Baker, SD

2013

Volltextzugriff (PDF)

Phase I trial of continuous infusion 5-aza-2'-deoxycytidine

Cancer chemotherapy and pharmacology, 2003-03, Vol.51 (3), p.231-239

2003

Volltextzugriff (PDF)

1 – 25 von 295

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(271)
Mit Volltextzugriff
(240)

Publikationsform

Sprache

Englisch
(295)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(280)
Life Sciences & Biomedicine
(223)
Humans
(134)
Biological And Medical Sciences
(107)
Female
(93)
Male
(93)
Medical Sciences
(86)
Adult
(65)
Animals
(60)
Physical Sciences
(56)
Middle Aged
(55)
Pharmacology. Drug Treatments
(53)
Oncology
(51)
Aged
(46)
Antineoplastic Agents
(33)
Chemotherapy
(31)
Neoplasms - Drug Therapy
(28)
Fundamental And Applied Biological Sciences. Psychology
(25)
Pharmacology & Pharmacy
(25)
Physics
(25)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Kinase Inhibitors: The Reality Behind the Success

E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia

The effects of pazopanib on doxorubicin pharmacokinetics in children and adults with non-rhabdomyosarcoma soft tissue sarcoma: a report from Children’s Oncology Group and NRG Oncology study ARST1321

Inherited variation in OATP1B1 is associated with treatment outcome in acute myeloid leukemia

Irinotecan Pathway Genotype Analysis to Predict Pharmacokinetics

Pharmacokinetic Considerations for New Targeted Therapies

Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity

Pharmacokinetics of 5-Azacitidine Administered With Phenylbutyrate in Patients With Refractory Solid Tumors or Hematologic Malignancies

Influence of OATP1B1 Function on the Disposition of Sorafenib‐β‐D‐Glucuronide

Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy

OATP1B1 Polymorphism as a Determinant of Erythromycin Disposition

A Phase I Dose Escalation and Bioavailability Study of Oral Sodium Phenylbutyrate in Patients with Refractory Solid Tumor Malignancies

ABCC4 Is a Determinant of Cytarabine‐Induced Cytotoxicity and Myelosuppression

Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function

Tumor Targeting by Covalent Conjugation of a Natural Fatty Acid to Paclitaxel

Ductal access for prevention and therapy of mammary tumors

Germline Polymorphisms in EGFR and Survival in Patients With Lung Cancer Receiving Gefitinib

Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometry

Population Pharmacokinetic Model for Docetaxel in Patients with Varying Degrees of Liver Function: Incorporating Cytochrome P450 3A Activity Measurements

Residual feed intake of purebred Angus steers: effects on meat quality and palatability

Effect of Common CYP3A4 and CYP3A5 Variants on the Pharmacokinetics of the Cytochrome P450 3A Phenotyping Probe Midazolam in Cancer Patients

A Phase I and Pharmacokinetic Study of Short Infusions of UCN-01 in Patients with Refractory Solid Tumors

Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: a dose escalation and pharmacologic study

College Students' Perceptions of MyPlate and ChooseMyPlate.gov

Phase I trial of continuous infusion 5-aza-2'-deoxycytidine

Aktive Filter

Suchergebnisse filtern